LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. LEN

Go back to LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression

Livanova (LIVN) PT Raised to $99 at Piper Sandler Following Earnings

April 28, 2021 1:33 PM EDT

Piper Sandler analyst Adam Maeder raised the price target on Livanova (NASDAQ: LIVN) to $99.00 (from $92.00) while maintaining a Overweight rating.

... More